scFv intrabody targeting wildtype TDP-43 presents protective effects in a cellular model of TDP-43 proteinopathy.
TDP-43 proteinopathies are neurological disorders marked by the abnormal accumulation of TDP-43 in the cytoplasm. This mislocalization disrupts the normal function of the protein. In most cases, it is the wildtype (wt) form of the protein that is involved. An untargeted high-throughput screen of a s...
Saved in:
| Main Authors: | Yara Al Ojaimi, Rudolf Hergesheimer, Anna A Chami, Hugo Alarcan, Johanna Augros, Audrey Dangoumau, Shanez Haouari, Jérôme Bourgeais, Antoine Lefevre, Samira Osman, Patrick Emond, Patrick Vourc'h, Christian R Andres, Philippe Corcia, Olivier Herault, Pierre Martineau, Débora Lanznaster, Hélène Blasco |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0322021 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
scFv intrabody targeting wildtype TDP-43 presents protective effects in a cellular model of TDP-43 proteinopathy
by: Yara Al Ojaimi, et al.
Published: (2025-01-01) -
Molecular mechanisms and consequences of TDP-43 phosphorylation in neurodegeneration
by: Elise A. Kellett, et al.
Published: (2025-05-01) -
Coding and non-coding RNA expression in NSC34 cells following TDP-43 depletion and mutant TDP-43 M337V expression
by: Ismail Gbadamosi, et al.
Published: (2025-07-01) -
Extracellular vesicles in TDP-43 proteinopathies: pathogenesis and biomarker potential
by: Elizabeth R. Dellar, et al.
Published: (2025-06-01) -
Nuclear pore complex dysfunction drives TDP-43 pathology in ALS
by: O. Ramírez-Núñez, et al.
Published: (2025-10-01)